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RIP3 is an essential upstream kinase in necroptosis.
The pseudokinase MLKL functions as a substrate of
RIP3 to mediate downstream signaling. The mole-
cular mechanism by which RIP3 recognizes and
phosphorylates MLKL remains unknown. Here, we
report the crystal structures of the mouse RIP3
kinase domain, the MLKL kinase-like domain, and a
binary complex between the two. Both RIP3 and
MLKL adopt the canonical kinase fold. Free RIP3
exists in an active conformation, whereas MLKL-
bound RIP3 is stabilized by AMP-PNP to adopt
an inactive conformation. The formation of the
RIP3-MLKL complex, involving their respective N-
and C-lobes, is accompanied by pronounced con-
formational changes of the aC helix and activation
loop in RIP3 and the corresponding structural
elements inMLKL. RIP3-mediatedMLKL phosphory-
lation, though important for downstream signaling,
is dispensable for stable complex formation between
RIP3 and MLKL. Our study serves as a framework
for mechanistic understanding of RIP3-mediated
necroptotic signaling.
INTRODUCTION
Necroptosis, also known as programmed necrosis, refers to
death-receptor-initiated cell death under conditions where the
execution of apoptosis is prevented (Christofferson and Yuan,
2010; Vandenabeele et al., 2010). Necroptosis is closely asso-
ciated with diseases, exemplified by its role in the pathogenesis
of ischemic injury, neurodegeneration, and viral infection
(Vandenabeele et al., 2010). Consequently, understanding the
molecular mechanisms of necroptosis is important for potential
therapeutic intervention.
In response to tumor necrosis factor (TNF)-a activation, two
conserved Ser/Thr protein kinases RIP1 (Stanger et al., 1995)
and RIP3 (Sun et al., 1999; Yu et al., 1999) together form a multi-
meric complex, named necrosome, to initiate the necroptotic70 Cell Reports 5, 70–78, October 17, 2013 ª2013 The Authorsprocess (Cho et al., 2009; He et al., 2009). Both proteins contain
an N-terminal kinase domain and a RIP homotypic interaction
motif (RHIM) (Sun et al., 2002), and RIP1 also has an extra
C-terminal death domain (Stanger et al., 1995). The kinase do-
mains of RIP1 and RIP3 share 33% sequence identity and
53% sequence similarity, and the kinase activities of RIP1 and
RIP3 are essential for TNF-a-induced necroptosis (Cho et al.,
2009; He et al., 2009). The RHIM domains of RIP1 and RIP3
are thought to mediate homotypic interactions, facilitating for-
mation of the RIP1-RIP3 necrosome required for necroptosis
(Li et al., 2012; Sun et al., 2002). The mixed lineage kinase
domain-like protein (MLKL) and the mitochondrial protein phos-
phatase PGAM5 were recently found to function downstream of
RIP3 (Sun et al., 2012; Wang et al., 2012). The MLKL kinase-like
domain was so named because it lacks the canonical ATP-bind-
ing P-loop, the catalytic loop, or the activation loop. RIP3 directly
phosphorylates the pseudokinase MLKL at Thr357 and Ser358,
which appears to be critical for necroptosis execution (Sun et al.,
2012). Phosphorylation by RIP3 leads to enhanced phosphatase
activity of PGAM5, which dephosphorylates Drp1 to mediate
mitochondrial fragmentation and initiate necroptosis (Wang
et al., 2012).
MLKL consists of an N-terminal coiled-coil domain and a
C-terminal kinase-like domain. A small molecule named ne-
crosulfonamide can be covalently linked to Cys86 of MLKL
coiled-coil domain to block necrosis downstream of RIP3 activa-
tion (Sun et al., 2012). The C-terminal kinase-like domain of
MLKL is responsible for association with RIP3 (Sun et al.,
2012). Both RIP3 and MLKL are highly conserved, with 69%/
77% sequence identity/similarity for the kinase domains of hu-
man and mouse RIP3, and 69%/81% sequence identity/similar-
ity for the kinase-like domains of human and mouse MLKL.
Despite an essential role of RIP3 and MLKL in necroptosis,
there is no atomic-resolution structure on either protein. The
lack of structural information has hindered functional and mech-
anistic understanding of the RIP3 kinase-mediated MLKL phos-
phorylation and signaling. In this study, we present the crystal
structures of the mouse RIP3 kinase domain, the mouse MLKL
kinase-like domain, and the RIP3-MLKL complex. Our results
reveal the structural and biochemical basis for the recognition
and phosphorylation of MLKL kinase-like domain by RIP3 kinase
domain.
Figure 1. Overall Structure of the Mouse
RIP3 Kinase Domain
(A) Overall structure of the mouse RIP3 kinase
domain (colored green). The P-loop (residues 29–
36) and the aC helix (residues 57–66) are colored
pink and purple, respectively. The activation loop
(residues 161–194) is highlighted in red; residues
171–185 are disordered in the crystals. All struc-
tural figures were prepared with PyMOL (DeLano,
2002).
(B) Lys51 forms a H-bond with Glu61 from the aC
helix of RIP3. The side chains of Lys51 and Glu61
are shown in sticks. H-bonds in this and all other
figures are represented by red dashed lines.
(C) H-bond between Phe162 and Ser165 of RIP3
helps to stabilize the DFG motif in the active
configuration.
(D) The hydrophobic spine structure in RIP3. The
side chains of the four amino acids, shown in
sticks, stack against each other in a linear fashion.
(E) Crystal lattice packing interactions between
two RIP3 molecules in an asymmetric unit. The
side chain of Arg69 in one molecule (Mol B) makes
two H-bonds to the main chain groups of Val66
and Leu76 in the other molecule (Mol A), and vice
versa.
See also Figure S1.RESULTS AND DISCUSSION
Overall Structure of the RIP3 Kinase Domain
We crystallized the mouse RIP3 kinase domain (residues 1–313)
with a C111A mutation, which has no detectable impact on the
kinase activity of RIP3 (data not shown) and determined its struc-
ture by molecular replacement using the atomic coordinates of
human RIP1 kinase domain (Protein Data Bank [PDB] ID code
4ITH) (Xie et al., 2013). The atomic model was refined at 2.4 A˚
resolution (Figure 1A; Table S1).
There are two molecules of RIP3 kinase domain in each asym-
metric unit. Because these two molecules display identical fea-Cell Reports 5, 70–78tures relevant for discussion, we only
focus on one such molecule. RIP3
exhibits a canonical kinase fold, with an
N-lobe, a C-lobe, and an intervening
activation loop (residues 161–194, also
known as T-loop). The N-lobe comprises
an antiparallel, five-stranded b-sheet
and an activation helix (residues 57–66,
commonly known as the aC helix) (Fig-
ures 1A and S1A). The C-lobe contains
eight a-helices and a pair of b-strands.
All essential amino acids for ATP binding
and hydrolysis in canonical kinases are
conserved in RIP3, including the catalytic
triad residues Lys51/Glu61/Asp161 and
key residues in the P-loop (residues 29–
36) and catalytic loop (residues 141–148).
Structural comparison between RIP3
and the catalytic subunit of protein kinaseA (PKA; PDB ID code 2CPK) (Knighton et al., 1991a, 1991b) sug-
gests that the free RIP3 kinase domain adopts an active confor-
mation (Figure S1B). The active kinase PKA contains a salt
bridge between Lys72 and Glu91, which helps Lys72 to stabilize
ATP through H-bonds to the a- and b-phosphates. Similarly, the
corresponding amino acids Lys51 and Glu61 in the RIP3 kinase
domain form a salt bridge (Figures 1B and S1B). In addition, the
configuration of the Asp-Phe-Gly (DFG) motif in the activation
loop of RIP3, which contains a conserved H-bond between
carbonyl oxygen of Phe162 and amide nitrogen of Ser165 (the
DFG + 2 residues) to helpmaintain the kinase in an active confor-
mation, is quite similar to that in PKA (Kornev et al., 2006), October 17, 2013 ª2013 The Authors 71
(Figures 1C and S1C). Furthermore, similar to other active pro-
tein Ser/Thr kinases (Kornev et al., 2006), RIP3 also contains
an assembled hydrophobic spine structure in which four hydro-
phobic amino acids stack against each other in a spatially linear
order (Figures 1D and S1D). This structural feature stabilizes the
kinase fold and helps the kinase to go through open and closed
conformations during catalysis (Kornev et al., 2006). The hydro-
phobic spine of RIP3 comprises Leu76, Met65, Phe162, and
His141, which correspond to Leu106, Leu95, Phe185, and
Tyr164, respectively, in PKA (Figures 1D and S1D).
The two molecules of RIP3 kinase domain in an asymmetric
unit pack against each other and exhibit a pseudo 2-fold symme-
try (Figure 1E). The side chain of Arg69 in one molecule donates
two H-bonds to the main chains of Val66 and Leu76 in the other
molecule, and vice versa (Figure 1E). These H-bondsmay help to
stabilize the aC helix and the hydrophobic spine, allowing the ki-
nase to maintain an active conformation.
Formation of the RIP3-MLKL Complex and
Phosphorylation of MLKL by RIP3
On the basis of cellular coimmunoprecipitation data, the kinase
domain of RIP3 was reported to directly interact with the
kinase-like domain of MLKL (Chen et al., 2013; Sun et al.,
2012). We expressed and purified the mouse RIP3 kinase
domain and the mouse MLKL kinase-like domain. However,
the individually purified RIP3 kinase domain (RIP3-KD, residues
1–318) and MLKL kinase-like domain (MLKL-KL, residues 182–
464) failed to form a stable complex as judged by gel filtration
analysis (Figure 2A). Only when coexpressed together in insect
cells, RIP3-KD and MLKL-KL formed a stable complex (Fig-
ure 2A). This result suggests that formation of the RIP3-MLKL
complex may depend on specific phosphorylation states of
these two proteins.
The binding of MLKL by RIP3 results in the phosphorylation of
MLKL kinase-like domain in vivo (Chen et al., 2013; Sun et al.,
2012). We sought to reconstitute an in vitro kinase activity assay
of RIP3 toward MLKL and determine the MLKL phosphorylation
sites (Figure 2B). Subsequent analysis by mass spectrometry
(MS) revealed that Ser345, Ser347, Thr349, and Ser352 of
MLKL kinase-like domain were phosphorylated by the RIP3
kinase domain (Figure S2A). These four phosphorylation sites
in MLKL were further confirmed by in vitro kinase activity assay
(Figure 2B). Single missense mutation in MLKL, involving any
of the four potential phosphorylation residues Ser345/Ser347/
Thr349/Ser352 to Ala or Glu, still allowed RIP3-mediated phos-
phorylation. By contrast, the quadruple mutants ST4A (S345A/
S347A/T349A/S352A) and ST4E (S345E/S347E/T349E/S352E)
completely abrogated RIP3-mediated phosphorylation. In addi-
tion, theMLKL quadruple variant ST4A or ST4E retained the abil-
ity to form a stable complex with coexpressed RIP3 (Figures S2B
and S2C). Further data strongly suggest that additional phos-
phorylation of RIP3, instead of MLKL, is required for stable
RIP3-MLKL complex formation (see the Extended Results and
Discussion; Figures S2B–S2D).
We crystallized the mouse MLKL kinase-like domain (residues
182–464) and determined its structure bymolecular replacement
using the atomic coordinates of humanMLKL kinase-like domain
(which will be discussed later). The X-ray structure of the mouse72 Cell Reports 5, 70–78, October 17, 2013 ª2013 The AuthorsMLKL kinase-like domain was refined at 1.6 A˚ resolution (Fig-
ure 2C; Table S1). Despite lack of the catalysis-related sequence
elements, the mouseMLKL kinase-like domain displays a kinase
fold with N- and C-lobes that are generally indistinguishable to
other protein kinases. The N-lobe comprises an antiparallel,
five-stranded b-sheet and an a-helix, whereas the C-lobe con-
tains seven a-helices and a pair of b-strands (Figures 2C and
S2E). All four residues that are phosphorylated by RIP3 are
located at the intervening loop region between the N- and
C-lobes of MLKL, of which two residues Ser345 and Ser347
were modeled on the basis of clear electron density.
Structure of the RIP3-MLKL Complex
To elucidate themechanism of MLKL recognition and phosphor-
ylation by RIP3, we sought to crystallize a binary complex
between RIP3 and MLKL. After numerous trials, we were able
to generate crystals of the complex between mouse RIP3
(residues 1–318) and mouse MLKL (residues 182–464) in the
presence of 2 mM adenosine 50-[b,g-imido]triphosphate (AMP-
PNP; a nonhydrolyzable ATP analog) in the C2221 space group.
The complex structure was determined by molecular replace-
ment using the atomic coordinates of mouse MLKL kinase-like
domain and mouse RIP3 kinase domain. The atomic model
was refined to 2.5 A˚ resolution (Figures 3A and S3A; Table S1).
The mouse RIP3 kinase domain forms a 1:1 complex with the
kinase-like domain of MLKL (Figure 3A). RIP3 and MLKL are
aligned in a parallel fashion, with the N- and C-lobes of RIP3
packing closely against the N- and C-lobes of MLKL, respec-
tively (Figures 3A, 3B, and S3A). Consequently, the RIP3-MLKL
interface comprises two separate contact areas, one involving
strands b1/b5 of RIP3 and a1/b4 ofMLKL, and the other involving
a7-a8 of RIP3 and a4-a6 of MLKL. The kinase-like domain of
MLKL and the RIP3 kinase domain are related to each other by
an approximate 90-degree rotation around a vertical axis. In
addition, RIP3 is stabilized by an AMP-PNP molecule (Figures
3A and S3B). MS analysis showed that both RIP3 and MLKL
are phosphorylated in the complex. The phosphorylation sites
in RIP3 are clearly visible; however, the loop region between
the N- and C-lobes of MLKL (residues 345–357), where the
known phosphorylation sites are located, is disordered in the
complex structure (Figure 3).
Interface between RIP3 and MLKL
The RIP3-MLKL interactions involve extensive van der Waals
contacts and numerous H-bonds (Figures 3B–3E). At the center
of the interface mediated by the N-lobes of RIP3 and MLKL,
two phenyl rings from Phe27 of RIP3 and Phe234 of MLKL
stack against each other through p-p interactions (Figure 3C).
The importance of these p-p interactions is manifested by the
greatly diminished association between RIP3 and MLKL as a
consequence of the missense mutation F27E or F234E (Fig-
ure S3C). These p-p interactions are buttressed by van der
Waals contacts between Phe87 of RIP3 and Val229/Ile259 of
MLKL. In addition, the hydroxyl group of Ser228 in MLKL
accepts a H-bond from the side chain of Lys56 in RIP3 and
donates a H-bond to Ser89; the hydroxyl group of Thr235 in
MLKL accepts a H-bond from the ε-amino group of Lys30 in
RIP3 (Figure 3C).
Figure 2. In Vitro Binding and Phosphorylation of MLKL by RIP3
(A) Analysis of the interactions between mouse RIP3 kinase domain (RIP3-KD) andmouse MLKL kinase-like domain (MLKL-KL) by gel filtration. The same elution
fractions of each gel filtration run were applied to SDS-PAGE followed by Coomassie blue staining. Individually expressed and purified RIP3 and MLKL failed to
form a stable complex, whereas coexpressed RIP3 and MLKL formed a stable complex.
(B) In vitro phosphorylation of wild-type and mutant MLKL by RIP3. MLKL was phosphorylated at Ser345, Ser347, Thr349, and Ser352. Mutation of any of these
four residues to Ala or Glu still allowed phosphorylation by RIP3, whereas the quadruple mutants S345A/S347A/T349A/S352A (ST4A) and S345E/S347E/T349E/
S352E (ST4E) failed to be phosphorylated.
(C) Overall structure of mouse MLKL kinase-like domain (colored cyan). The four phosphorylation sites by RIP3 are located at an intervening region between the
N- and C-lobes of MLKL. Ser345 and Ser347 are colored red, and Thr349 and Ser352 are disordered and invisible.
See also Figure S2.
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Figure 3. Structure of the Mouse RIP3-
MLKL Complex and the Interface between
RIP3 and MLKL
(A) Overall structure of the mouse RIP3-MLKL
complex. The RIP3 kinase domain and MLKL ki-
nase-like domain are colored green and cyan,
respectively. AMP-PNP is shown in magenta ball
and stick.
(B) The interface between the N- and C-lobes of
RIP3 and MLKL. The interface residues are shown
in sticks.
(C) A close-up view of the N-lobe interface be-
tween RIP3 and MLKL.
(D) A close-up view of the H-bond network in the
C-lobe interface between RIP3 and MLKL.
(E) A close-up view of the hydrophobic interactions
in the C-lobe interface between RIP3 and MLKL.
The right panel shows the hydrophobic cavity
surrounding Phe373 from MLKL.
See also Figure S3.At the interface mediated by the C-lobes of RIP3 and MLKL,
there are six discrete H-bonds and an area of concentrated
van der Waals contacts. Notably, Ser232 appears to play an
important role upon phosphorylation; the phosphate group of
the phosphorylated Ser232 in RIP3 accepts a H-bond from the
hydroxyl group of Ser404 in MLKL (Figure 3D). The side chains
of Lys230, Glu236, and Arg241 in RIP3 each makes a H-bond
to the side chains of Ser360, Lys405, and Glu413 in MLKL,
respectively (Figure 3D). There are also two H-bonds involving
the main chain groups, between Arg244 of RIP3 and Asn371 of
MLKL, and between Arg223 of RIP3 and Phe373 of MLKL.
Most notably, the phenyl ring of Phe373 inMLKL inserts into a hy-
drophobic pocket formed by the side chains of Ala189, Tyr210,
Ile214, Leu227, Ile234, Val238, and Pro245 in RIP3 (Figure 3E).
To further corroborate the binding interface between RIP3 and
MLKL, we performed mutational analysis. Consistent with a key
role by the hydrophobic contacts, the mutation of Phe373 to Ala
or Arg in MLKL led to complete disruption of the formation of
RIP3-MLKL complex (Figure S3D). In addition, the mutation
S404A in MLKL or the mutation S232A/S232D/S232E greatly
attenuated formation of the RIP3-MLKL complex (Figure S3E).74 Cell Reports 5, 70–78, October 17, 2013 ª2013 The AuthorsThis result strongly suggests an important
role by Ser232 phosphorylation in the
formation of RIP3-MLKL complex, con-
firming an earlier observation (Sun et al.,
2012). In contrast to the phosphoryla-
tion-dependent H-bond, other H-bonds
appear to play a less important role,
because disruption of an individual
H-bond by K230A/E236A in RIP3 or
K405 in MLKL had little impact on for-
mation of the RIP3-MLKL complex (Fig-
ure S3E). Finally, as anticipated, the
double mutations S404A/K405A in MLKL
(SK2A) or the triple mutations K230A,
S232A, and E236A in RIP3 (KSE3A)
attenuated formation of the RIP3-MLKL
complex (Figure S3E).The human MLKL T357A/S358A mutant was previously re-
ported to have a dominant-negative effect on necrosis (Sun
et al., 2012). The corresponding phosphorylation site mutants
of mouse MLKL (ST4A and ST4E) retained formation of the
RIP3-MLKL complex (Figure S3F). This result suggests that
physical association between RIP3 and MLKL is insufficient to
mediate necrosis signaling and the RIP3-mediated phosphoryla-
tion of MLKL is crucial. Intriguingly, besides Ser232, two addi-
tional phosphorylated residues, Ser184 and Thr231 in RIP3,
were observed in the RIP3-MLKL complex structure. Because
Thr231 of RIP3 is not involved in the interfacewithMLKL, themu-
tation T231A/T231D/T231E had little impact on formation of the
RIP3-MLKL complex (Figure S3G). Similar to S232A/S232D/
S232E, the double mutations T231A/S232A (TS2A), T231D/
S232D (TS2D), or T231E/S232E (TS2E) in RIP3 attenuated for-
mation of the RIP3-MLKL complex (Figure S3G).
Inactive Conformation of MLKL-Bound RIP3
MLKL-bound RIP3 exhibits a root-mean-squared deviation
(rmsd) value of 0.64 A˚ over 227 aligned Ca atoms with free
RIP3 (Figure 4A). Despite the overall structural similarity,
Figure 4. Conformational Changes of RIP3
and MLKL upon RIP3-MLKL Complex For-
mation
(A) Structural comparison of free RIP3 and MLKL-
bound RIP3. Free RIP3 is colored yellow, with its
aC helix in magenta and T-loop in orange. MLKL-
bound RIP3 is colored green, with its aC helix in
purple and T-loop in red. AMP-PNP is shown in
magenta sticks.
(B) A close-up view of the conformational change in
the N-lobe of RIP3 in response to MLKL binding.
The side chains of Ser228 from MLKL and Lys56
and Ser89 from RIP3 are shown in sticks.
(C) The movement of aC helix leads to disruption of
the salt bridge between Lys51 and Glu61 in RIP3.
(D) A close-up view of the conformational change
in the DFG motif of RIP3 in response to MLKL
binding.
(E) A close-up view of the rearrangement of the
hydrophobic spine structure in RIP3 in response to
MLKL binding.
(F) Structural comparison of free MLKL and RIP3-
boundMLKL. FreeMLKL is colored orange, with its
a1 and a4 helices in pink. RIP3-bound MLKL is
colored cyan, with its a1 and a4 helices in yellow.
RIP3 is represented in green surface. AMP-PNP is
shown in magenta sticks.
(G) A close-up view of the conformational changes
of the residues in the N-lobe of MLKL in response
to RIP3 binding. The residues are shown in sticks.
See also Figure S4.comparison between free RIP3 and MLKL-bound RIP3 reveals a
drastic conformational change involving the aC helix and the
activation loop (Figures 4A and 4B). Association with MLKL re-
sults in the formation of two H-bonds from the hydroxyl group
of Ser228 in MLKL to the side chains of Lys56 and Ser89 in
RIP3, of which Lys56 undergoes a pronounced rotation (Fig-
ure 4B). The aC helix is shifted by about 5 A˚ and its N-terminal
portion is unwound (Figure 4B), moving Glu61 out of H-bond
distance range of Lys51 (Figure 4C). Consequently, Glu61 is
separated from Lys51 by about 16 A˚, and the side chain of
Lys51 donates a H-bond to the a-phosphate group of AMP-
PNP (Figures 4C and S4A).
In addition to the rearrangement of aC helix in MLKL-
bound RIP3, the DFG motif in the activation loop also adopts a
different conformation, which is stabilized by a network of inter-Cell Reports 5, 70–7actions involving AMP-PNP, the mag-
nesium ion, and Lys51 (Figures 4D and
S4A). Lys51 donates two H-bonds, one
to Asp161 and the other to the a-phos-
phate group of AMP-PNP, whereas
magnesium ion is coordinated by the
side chain of Asp161 and the phos-
phate groups of AMP-PNP. Conse-
quently, the conserved H-bond between
the carbonyl oxygen of Phe162 and
the amide nitrogen of Ser165 (the DFG +
2 residues), which helps maintain the
kinase in an active conformation, iseliminated (Figure 4D). Due to reorientation of the aC helix
and the activation loop, Met65 and Phe162 of the hydrophobic
spine move away from their original positions, breaking the
linear organization (Figure 4E). All these structural rearrange-
ments together maintain MLKL-bound RIP3 in an inactive
conformation.
The inactive conformation of MLKL-bound RIP3 is mainly
stabilized by AMP-PNP, which is located in a pocket close
to the P-loop and catalytic loop of RIP3 (see the Extended
Results and Discussion; Figures S4A and S4B). Structural
comparison of MLKL-bound RIP3 with a bisubstrate analog-
bound tyrosine kinase ABL1 (Levinson et al., 2006) reveals
that both the structures adopt the same local configurations
to maintain the kinases in the inactive conformation and
AMP-PNP in MLKL-bound RIP3 serves as an inhibitor to8, October 17, 2013 ª2013 The Authors 75
Figure 5. Homology Modeling of the Human RIP3-MLKL Complex
(A) A structural model of the human RIP3 kinase domain.
(B) The crystal structure of human MLKL kinase-like domain.
(C) A structural model of the human RIP3-MLKL complex. The human RIP3 and MLKL are colored dark green and light cyan, respectively.
(D) Structural comparison of the mouse RIP3-MLKL complex and the human RIP3-MLKL complex. The mouse RIP3 and MLKL are colored green and cyan,
respectively. The human RIP3 and MLKL are colored dark green and light cyan, respectively.
(E) Phe386 in humanMLKL inserts into a hydrophobic pocket in the C-lobe of human RIP3 on the basis of the modeled human RIP3-MLKL structure. The surface
of human RIP3 is represented by electrostatic potential. Phe386 is shown in sticks.
See also Figure S5.stabilize the RIP3-MLKL complex structure (see the Extended
Results and Discussion; Figures S4C–S4E).
Conformational Changes of MLKL upon Binding to RIP3
RIP3-bound MLKL exhibits an rmsd value of 0.86 A˚ over 213
aligned Ca atoms with free MLKL (Figure 4F). Structural compar-
ison between free MLKL and RIP3-bound MLKL reveals marked
conformational changes in the a1 and a4 helices (Figure 4F),
which correspond to the aC helix and the activation loop,
respectively, in a canonical kinase. Due to steric clash, the bind-
ing of RIP3 leads to relocation of the a1 helix (residues 229–242)
and the a4 helix and its ensuing loop (residues 336–360) in MLKL
(Figure 4F). The movement of the a1/a4 helices and the loop
following a4 results in rearrangement of the residues Ser228,76 Cell Reports 5, 70–78, October 17, 2013 ª2013 The AuthorsVal229, Phe234, Thr235, and Ser360, which facilitates the inter-
action between RIP3 and MLKL (Figure 4G).
Homology Modeling of the Human RIP3-MLKL Complex
The human RIP3 kinase domain shares 69% sequence identity
and 77% sequence similarity with the kinase domain of mouse
RIP3 (Figure S1A). Using the programs Modeler 9.11 (Eswar
et al., 2007) and JACKAL (Xiang et al., 2007), we generated a
structural model for the human RIP3 kinase domain on the basis
of the mouse RIP3 kinase domain structure (Figure 5A). In addi-
tion, we crystallized the human MLKL kinase-like domain and
determined its structure by molecular replacement using the
atomic coordinates of human RIP1 (PDB ID code 4ITH) (Xie
et al., 2013). The atomic model was refined to a resolution of
1.9 A˚ (Figure 5B; Table S1). The human RIP3 kinase domain
model and the human MLKL kinase-like domain structure were
individually superimposed onto the structure of the mouse
RIP3-MLKL complex; the resulting model was energy-minimized
using the molecular dynamics package Gromacs 4.5 (Pronk
et al., 2013) (Figure 5C).
As anticipated, the overall structure and interactions between
the human and mouse RIP3-MLKL complexes are quite similar
(Figure 5D). For example, Phe386 in human MLKL (correspond-
ing to Phe373 in mouse MLKL) is surrounded by a highly
conserved hydrophobic pocket in human RIP3 (Figure 5E).
Consistent with the important role of Ser227 phosphorylation in
human RIP3-MLKL complex formation, the phosphorylated
Ser227 in human RIP3 (corresponding to Ser232 in mouse
RIP3) accepts a H-bond from an invariable residue Ser417 in
human MLKL (corresponding to Ser404 in mouse MLKL) (Fig-
ure S5A). Notably, the N- or C-lobe interface between RIP3
and MLKL contains a number of species-specific interactions,
explaining the observation that human RIP3 and mouse MLKL,
ormouse RIP3 and humanMLKL, failed to form a stable complex
(Chen et al., 2013; Sun et al., 2012). In the N-lobe interface of
human RIP3-MLKL complex, the van der Waals contacts are
greatly diminished, and the conserved Ser239 in human MLKL
is predicted to form two H-bonds with two variable residues
Asp87 and Lys89 in human RIP3 (Figure S5B). Similarly, the
C-lobe interface H-bond network in human RIP3-MLKL complex
is rearranged to fit the species-specific interface, involving the
interactions mediated by the variable residues Glu225/Tyr230/
Asn235/Ser241 in human RIP3 and Asp384/Gln388 in human
MLKL (Figure S5A).
In summary, we report the crystal structures of the mouse
RIP3 kinase domain, MLKL kinase-like domain, and RIP3-
MLKL complex at atomic resolutions. Structural and biochemical
analyses reveal the molecular basis for the RIP3-mediated
recognition and phosphorylation of MLKL kinase-like domain.
The phosphorylation of MLKL by RIP3 is crucial for downstream
signaling. The phosphomimetic MLKL mutant, which remains
associated with RIP3, was reported to retain the ability to induce
necrosis (Sun et al., 2012). Together with this and other previous
reports, our study indicates that the binding between RIP3 and
MLKL is necessary, but not sufficient, for necrosis signaling.
Disruption of the binding interface between RIP3 and MLKL
prevents necroptosis downstream RIP3. Our structural and
biochemical studies allow improved delineation of RIP3-medi-
ated signaling events.EXPERIMENTAL PROCEDURES
The recombinant RIP3 protein and MLKL protein were overexpressed in Sf-9
insect cells and E. coli, respectively. The mouse RIP3-MLKL complex was
obtained by coexpression of RIP3 and MLKL in Sf-9 insect cells. All the pro-
teins were purified to homogeneity and crystallized by the hanging-drop
vapor-diffusion method. The data sets were collected at SPring-8 and
Shanghai Synchrotron Radiation Facility (SSRF). All the data sets were pro-
cessed with the HKL2000 (Otwinowski and Minor, 1997) and the CCP4 suite
(Collaborative Computational Project, 1994). The structures were determined
by molecular replacement using PHASER (McCoy et al., 2007). Manual model
rebuilding and refinement were iteratively performed with COOT (Emsley and
Cowtan, 2004) and PHENIX (Adams et al., 2002), respectively. The gel filtrationanalyses were performed to detect RIP3 andMLKL binding. The in vitro kinase
activity assay was used to detect the kinase activity of RIP3 toward MLKL.
Mass spectrometry analysis were performed to determine the phosphorylation
sites in RIP3 and MLKL.
See the Extended Experimental Procedures for details.
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